JP2015525770A5 - - Google Patents

Download PDF

Info

Publication number
JP2015525770A5
JP2015525770A5 JP2015522168A JP2015522168A JP2015525770A5 JP 2015525770 A5 JP2015525770 A5 JP 2015525770A5 JP 2015522168 A JP2015522168 A JP 2015522168A JP 2015522168 A JP2015522168 A JP 2015522168A JP 2015525770 A5 JP2015525770 A5 JP 2015525770A5
Authority
JP
Japan
Prior art keywords
diagnosis
therapy
activity inhibitor
inhibitor
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2015522168A
Other languages
English (en)
Japanese (ja)
Other versions
JP2015525770A (ja
Filing date
Publication date
Priority claimed from GBGB1212773.4A external-priority patent/GB201212773D0/en
Application filed filed Critical
Publication of JP2015525770A publication Critical patent/JP2015525770A/ja
Publication of JP2015525770A5 publication Critical patent/JP2015525770A5/ja
Withdrawn legal-status Critical Current

Links

JP2015522168A 2012-07-18 2013-07-18 血管再構築のためのＮｋｘ２．５阻害剤 Withdrawn JP2015525770A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1212773.4 2012-07-18
GBGB1212773.4A GB201212773D0 (en) 2012-07-18 2012-07-18 Vascular remodelling
PCT/GB2013/051916 WO2014013254A1 (en) 2012-07-18 2013-07-18 Inhibitors of nkx2.5 for vascular remodelling

Publications (2)

Publication Number Publication Date
JP2015525770A JP2015525770A (ja) 2015-09-07
JP2015525770A5 true JP2015525770A5 (OSRAM) 2016-09-08

Family

ID=46799797

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015522168A Withdrawn JP2015525770A (ja) 2012-07-18 2013-07-18 血管再構築のためのＮｋｘ２．５阻害剤

Country Status (5)

Country Link
US (1) US20150190391A1 (OSRAM)
EP (1) EP2874629A1 (OSRAM)
JP (1) JP2015525770A (OSRAM)
GB (1) GB201212773D0 (OSRAM)
WO (1) WO2014013254A1 (OSRAM)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP223198A0 (en) * 1998-03-06 1998-04-02 Fujisawa Pharmaceutical Co., Ltd. New use
EP2990487A1 (en) * 2008-05-08 2016-03-02 Asuragen, INC. Compositions and methods related to mirna modulation of neovascularization or angiogenesis
MX2012003997A (es) * 2009-10-02 2012-07-25 Cylene Pharmaceuticals Inc Biomarcadores para predecir la sensibilidad y respuesta de enfermedades mediadas por proteina cinasa ck2 a inhibidores de ck2.

Similar Documents

Publication Publication Date Title
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
IL285843A (en) Ibrutinib for use in the treatment of chronic graft versus host disease
JP2015503422A5 (OSRAM)
JP2014530840A5 (OSRAM)
IL242610A0 (en) History of pyrazolopyrrolidine and their use in the treatment of diseases
HUE040044T2 (hu) Fumarátok prodrugjai, és azok alkalmazása különbözõ betegségek kezelésében
JP2013188229A5 (OSRAM)
BR112015007494A2 (pt) aparelho para tratamento dentário.
JP2013525942A5 (OSRAM)
HUE049637T2 (hu) Toalettben lehúzható katéterek
DK3909966T3 (da) 19-nor c3,3-disubstitueret c21-n-pyrazolylsteroid til brug i behandling
BR302013006822S1 (pt) Configuração aplicada em curativo médico.
JP2011170856A5 (OSRAM)
HUE036943T2 (hu) Minigasztrin analóg, különösen CCK2-receptor pozitív tumor diagnosztikában és/vagy kezelésben történõ alkalmazásra
LT2945642T (lt) Faktoriaus 1 baltymas, skirtas naudoti ligų gydymui arba prevencijai
HRP20182134T1 (hr) Triazinski spoj i njegova upotreba u medicinske svrhe
JP2015173751A5 (OSRAM)
DK2816947T3 (da) Endoskopisk anordning, særlig til medicinsk brug
PL3236960T3 (pl) Fluralaner do zastosowania w leczeniu demodekozy
JP2013231052A5 (OSRAM)
PL2988750T5 (pl) Zastosowanie chlorowodorku landilolu w długotrwałym leczeniu tachyarytmii
JP2012044147A5 (OSRAM)
JP2014529579A5 (OSRAM)
JP2011170857A5 (OSRAM)
JP2011181497A5 (OSRAM)